Condition: Microvascular Disease · Sponsor: Johannes Gutenberg University Mainz
The evidence above demonstrates that microvascular dysfunction is an important determinant of patient prognosis, which however remains poorly classified. Given the high burden of disease and the severity of the functional impairment in these patients, the lack of a clear definition for this disease has a potentially large clinical importance. It is important to better describe the phenotype of these patients, identify the predictors of prognosis, and determine the impact of diagnosis.
This description comes directly from the study's public registry record.
Tommaso Gori, Dott med, PhD · +496131 17 · tommaso.gori@unimedizin-mainz.de
Always discuss trial participation with your own doctor first.
| Universitätsmedizin Mainz | Mainz, RLP, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04612322